ENTRY       K08060                      KO
NAME        CIITA
DEFINITION  class II, major histocompatibility complex, transactivator
PATHWAY     ko04612  Antigen processing and presentation
            ko05145  Toxoplasmosis
            ko05152  Tuberculosis
            ko05164  Influenza A
            ko05340  Primary immunodeficiency
DISEASE     H00093  Combined immunodeficiencies (CIDs)
            H00985  Bare lymphocyte syndrome (BLS) type2
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Organismal Systems
              Immune system
               04612 Antigen processing and presentation
                K08060  CIITA; class II, major histocompatibility complex, transactivator
             Human Diseases
              Immune diseases
               05340 Primary immunodeficiency
                K08060  CIITA; class II, major histocompatibility complex, transactivator
              Infectious diseases
               05152 Tuberculosis
                K08060  CIITA; class II, major histocompatibility complex, transactivator
               05164 Influenza A
                K08060  CIITA; class II, major histocompatibility complex, transactivator
               05145 Toxoplasmosis
                K08060  CIITA; class II, major histocompatibility complex, transactivator
GENES       HSA: 4261(CIITA)
            PTR: 453914(CIITA)
            PPS: 100973925(CIITA)
            GGO: 101129402(CIITA)
            PON: 100443575(CIITA)
            MCC: 710761(CIITA)
            MCF: 102129555(CIITA)
            MMU: 12265(Ciita)
            RNO: 85483(Ciita)
            CGE: 100768306(Ciita)
            HGL: 101721690(Ciita)
            TUP: 102493490(CIITA)
            CFA: 490008(CIITA)
            AML: 100480688
            FCA: 101087372(CIITA)
            PTG: 102949369(CIITA)
            BTA: 508720(CIITA)
            BOM: 102288153(CIITA)
            PHD: 102321077(CIITA)
            CHX: 102172509(CIITA)
            SSC: 100624181 100736732(CIITA)
            CFR: 102511845(CIITA)
            BACU: 103002051(CIITA)
            LVE: 103090163(CIITA)
            ECB: 100056546(CIITA)
            MYB: 102241757(CIITA)
            MYD: 102768592(CIITA)
            PALE: 102889981(CIITA)
            MDO: 100025589(CIITA)
            SHR: 100919223(CIITA)
            OAA: 100086874(CIITA)
            GGA: 416633
            TGU: 100223542(CIITA)
            FAB: 101807335(CIITA)
            PHI: 102100060(CIITA)
            APLA: 101803334(CIITA)
            FPG: 101924238(CIITA)
            FCH: 102050171(CIITA)
            CLV: 102084039(CIITA)
            ASN: 102382843(CIITA)
            AMJ: 102563112(CIITA)
            PSS: 102452474(CIITA)
            CMY: 102938017(CIITA)
            PBI: 103068016(CIITA)
            XTR: 101734303(ciita)
            DRE: 100003537(ciita)
            TRU: 101061033
            MZE: 101485006
            OLA: 101173371
            XMA: 102238233
            LCM: 102357559(CIITA)
            CMK: 103186082(ciita)
REFERENCE   PMID:11003667
  AUTHORS   Hake SB, Masternak K, Kammerbauer C, Janzen C, Reith W, Steimle V
  TITLE     CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
  JOURNAL   Mol Cell Biol 20:7716-25 (2000)
///
